Multimodal Photodynamic Therapy by Inhibiting the Nrf2/ARE Signaling Pathway in Tumors
ACS Biomaterials Science & Engineering · 2024
DOI: 10.1021/acsbiomaterials.4c01643 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2024. Verfasst von Xin Duan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Photochemotherapy, Signal Transduction, NF-E2-Related Factor 2, Photosensitizing Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Förderung
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Duan, X., Xue, B., Xu, Z., & Niu, Z. (2024). Multimodal Photodynamic Therapy by Inhibiting the Nrf2/ARE Signaling Pathway in Tumors. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c01643
Vancouver
Duan X, Xue B, Xu Z, Niu Z. Multimodal Photodynamic Therapy by Inhibiting the Nrf2/ARE Signaling Pathway in Tumors. ACS Biomaterials Science & Engineering. 2024. doi:10.1021/acsbiomaterials.4c01643
BibTeX
@article{Duan2024,
author = {Duan, Xin and Xue, Bingjian and Xu, Zimeng and Niu, Zixu},
title = {Multimodal Photodynamic Therapy by Inhibiting the Nrf2/ARE Signaling Pathway in Tumors},
journal = {ACS Biomaterials Science & Engineering},
year = {2024},
doi = {10.1021/acsbiomaterials.4c01643}
}
EUVIMED